Sezzle (SEZL) had the highest return between October 1, 2023 and September 30, 2024 by a mid-cap US stock, returning 1,190.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sezzle (SEZL) | 10/1/2023 - 9/30/2024 | 1,190.41% |
GeneDx (WGS) | 10/1/2023 - 9/30/2024 | 1,092.13% |
Dave (DAVE) | 10/1/2023 - 9/30/2024 | 521.46% |
Viking Therapeutics (VKTX) | 10/1/2023 - 9/30/2024 | 475.55% |
ADMA Biologics (ADMA) | 10/1/2023 - 9/30/2024 | 459.94% |
Lumen Technologies (LUMN) | 10/1/2023 - 9/30/2024 | 407.14% |
Edgewise Therapeutics (EWTX) | 10/1/2023 - 9/30/2024 | 365.79% |
CareDx (CDNA) | 10/1/2023 - 9/30/2024 | 347.99% |
Aveanna Healthcare (AVAH) | 10/1/2023 - 9/30/2024 | 340.68% |
Pulse Biosciences (PLSE) | 10/1/2023 - 9/30/2024 | 334.16% |
CAVA (CAVA) | 10/1/2023 - 9/30/2024 | 307.4% |
Impinj (PI) | 10/1/2023 - 9/30/2024 | 292.6% |
Dyne Therapeutics (DYN) | 10/1/2023 - 9/30/2024 | 290.43% |
Oscar Health (OSCR) | 10/1/2023 - 9/30/2024 | 285.64% |
Banco Macro SA B ADR (BMA) | 10/1/2023 - 9/30/2024 | 260.11% |
Zeta Global (ZETA) | 10/1/2023 - 9/30/2024 | 258.97% |
Grupo Financiero Galicia SA ADR (GGAL) | 10/1/2023 - 9/30/2024 | 249.49% |
Tutor Perini (TPC) | 10/1/2023 - 9/30/2024 | 248.65% |
Terawulf (WULF) | 10/1/2023 - 9/30/2024 | 229.58% |
Vera Therapeutics (VERA) | 10/1/2023 - 9/30/2024 | 224.05% |
IES (IESC) | 10/1/2023 - 9/30/2024 | 203.05% |
Perimeter Solutions (PRM) | 10/1/2023 - 9/30/2024 | 198.89% |
BBVA Banco Frances SA ADR (BBAR) | 10/1/2023 - 9/30/2024 | 197.19% |
Modine Manufacturing (MOD) | 10/1/2023 - 9/30/2024 | 191.65% |
Hims Hers Health (HIMS) | 10/1/2023 - 9/30/2024 | 191% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.